Molecular breast imaging (MBI) is a functional imaging test that uses a small amount of radioactive tracer injected into your bloodstream to detect breast cancer. Unlike mammography, which creates an image based on breast tissue density, MBI highlights areas of increased cellular activity, making it especially useful for women with dense breast tissue where mammograms can miss tumors.
How MBI Works
Before the scan, you receive an intravenous injection of a radioactive tracer called technetium-99m sestamibi. This tracer travels through your bloodstream and gets taken up by cells throughout your body, but it concentrates more heavily in cells that are rapidly dividing and have high blood flow. Cancer cells fit that profile. The tracer accumulates inside the mitochondria (the energy-producing structures) of tumor cells, making them light up on the imaging camera.
Your breasts are then positioned between two small gamma cameras that detect the radiation emitted by the tracer. These cameras create a functional map of your breast tissue, showing areas of increased uptake as bright spots. Because the technique relies on cellular behavior rather than tissue structure, it performs equally well regardless of how dense your breast tissue is. Interestingly, MBI can also identify benign but rapidly growing tissue that may carry an increased risk of developing into cancer later.
Who Should Consider MBI
The primary candidates fall into two groups: women with dense breast tissue and women at elevated lifetime risk of breast cancer.
Dense breast tissue, classified as category C (heterogeneously dense) or D (extremely dense) on a mammogram, affects roughly half of women undergoing screening. Dense tissue is associated with larger and more aggressive tumors at diagnosis, higher rates of cancers found between regular screenings, greater likelihood of lymph node involvement, and increased use of mastectomy. Standard mammography struggles in these cases because dense tissue and tumors both appear white on the image, effectively camouflaging cancers. MBI sidesteps this problem entirely.
Women at high lifetime risk include those with BRCA gene mutations, untested first-degree relatives of BRCA carriers, women who received chest radiation between ages 10 and 30, and anyone with a calculated lifetime breast cancer risk above 20% based on standard risk models. For high-risk women, breast MRI is typically the first-line supplemental screening tool. But MBI serves as a reasonable alternative for patients who cannot undergo MRI due to claustrophobia, kidney problems, implanted devices, or other contraindications.
What the Exam Feels Like
You’ll need to avoid food and non-clear fluids (like milk) for at least three hours before your appointment. When you arrive, a technologist places an IV line and injects the tracer. After a short wait for the tracer to circulate, you sit in front of the imaging unit.
The equipment lightly compresses each breast between two detector panels, similar to a mammogram but with notably less pressure. Most patients find it more comfortable than a standard mammogram. The scan itself takes 20 to 40 minutes. You’ll typically have images taken from two angles per breast. The whole appointment, including prep and injection, usually runs about an hour.
The Technology Behind the Cameras
Early MBI systems used the same type of gamma cameras found in nuclear medicine departments, which produced decent but limited images. The shift to dedicated dual-head cameras with cadmium zinc telluride (CZT) semiconductor detectors changed the field significantly. These solid-state detectors distinguish energy signals far more precisely than older technology, with energy resolution roughly twice as sharp. In practical terms, they can identify structures as small as 3.1 millimeters in diameter.
This improvement in detector quality also meant the tracer dose could drop substantially. Older systems required 740 to 1,100 megabecquerels (20 to 30 millicuries) of tracer. Newer dual-head systems achieve the same diagnostic performance with just 240 to 300 megabecquerels (6.5 to 8 millicuries), cutting the radiation exposure by roughly two-thirds.
Radiation Dose Compared to Mammography
MBI does deliver more radiation than a standard mammogram. A two-view digital mammogram exposes breast tissue to a small, localized dose, while MBI involves a systemic injection that distributes radiation throughout the body. Even with the lower-dose protocols now standard on modern systems, the effective whole-body dose from MBI remains higher than from mammography alone.
This is the main reason MBI hasn’t replaced mammography as a first-line screening tool for everyone. The benefit-to-risk ratio favors MBI when the alternative is missing a cancer that mammography can’t see, which is why it’s targeted at women with dense tissue or elevated risk rather than used as a universal screening method.
How MBI Compares to Other Screening Options
Several technologies compete in the supplemental screening space for women with dense breasts: breast ultrasound, contrast-enhanced mammography, standard MRI, abbreviated MRI, and MBI. Each comes with trade-offs.
- Breast ultrasound is widely available and uses no radiation, but it produces more false positives and is highly dependent on the skill of the person performing it.
- Breast MRI has the highest sensitivity for detecting cancer and is the gold standard for high-risk screening, but it’s expensive, requires contrast dye injection, takes longer, and isn’t tolerable for everyone.
- MBI offers sensitivity comparable to MRI for invasive cancers in dense breasts, costs less, takes less time, and is generally better tolerated. Its main disadvantage is the radiation exposure.
For women who qualify for MRI and can tolerate it, MRI remains the preferred choice. MBI fills an important gap for everyone else.
Who Should Not Have MBI
MBI is not recommended during pregnancy due to the radiation exposure from the tracer. It’s also generally avoided if you’re breastfeeding, since the radioactive material can pass into breast milk. Allergic reactions to the tracer are extremely rare but possible, so let your provider know about any allergies beforehand. There are no restrictions related to breast implants, body size, or metal implants, which gives MBI an advantage over MRI in certain populations.